The burden of the rheumatic diseases in the general adult population of Greece: the ESORDIG study

Andrianakos, A.; Miyakis, Spiros; Trontzas, Panagiotis; Kaziolas, G; Christoyannis, Fotis; Karamitsos, D; Karanikolas, George; Dantis, P.

doi:10.1093/rheumatology/keh650

Cited by 37 publications

(33 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Arthritis is one of the most prevalent and pervasive chronic conditions affecting middle-aged and older adults [ 1 , 2 ]. It contributes substantially to global healthcare expenditure and is a major cause of disability, limited mobility and chronic pain [ 3 , 4 ].…”

Section: Introductionmentioning

confidence: 99%

“Just Get on with It”: Qualitative Insights of Coming to Terms with a Deteriorating Body for Older Women with Osteoarthritis

et al. 2015

View full text Add to dashboard Cite

ObjectiveTo qualify the psychosocial burden of osteoarthritis for older women and identify factors perceived to assist with psychological adjustment to the disease.MethodsWomen who indicated being diagnosed/treated for osteoarthritis in the previous three years in the fifth survey of the Australian Longitudinal Study on Women’s Health provided the sampling frame. Participants were randomly sampled until saturation was reached using a systematic process. Thematic content analysis was applied to the 19 semi-structured telephone interviews using a realist framework.ResultsThe findings indicate that the emotional burden of osteoarthritis is considerable, and the process of psychological adjustment complex. Older women with osteoarthritis have psychological difficulties associated with increasing pain and functional impairment. Psychological adjustment over time was attributed primarily to cognitive and attitudinal factors (e.g. stoicism, making downward comparisons and possessing specific notions about the cause of arthritis). This was a dynamic ‘day to day’ process involving a constant struggle between grieving physical losses and increasing dependence amidst symptom management.ConclusionThe findings of this study add to the current understanding of the complex processes involved in psychological adjustment over time. Targeted interventions focused on assisting women with arthritis redefine self-concepts outside the confines of caring responsibilities, coupled with public health education programs around understanding the destructive nature of arthritis are required. Understanding the destructive and (potentially) preventable nature of arthritis may facilitate early detection and increased uptake of appropriate treatment options for osteoarthritis that have the ability to modify disease trajectories.

show abstract

Section: Introductionmentioning

confidence: 99%

“Just Get on with It”: Qualitative Insights of Coming to Terms with a Deteriorating Body for Older Women with Osteoarthritis

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Regarding resource use several studies have reported RMDs as one of the main causes of frequent healthcare utilization [23,24]. Although our GBD-based approach suggested a weak association between RMDs and healthcare utilization in comparison with other chronic conditions, a high population impact was found.…”

Section: Discussionmentioning

confidence: 55%

The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches

et al. 2018

View full text Add to dashboard Cite

The aim of this study was to quantify the population impact of rheumatic and musculoskeletal diseases (RMDs) with other non-communicable diseases (NCDs), using two complementary strategies: standard multivariate models based on global burden of disease (GBD)-defined groups vs. empirical mutually exclusive patterns of NCDs. We used cross-sectional data from the Portuguese Fourth National Health Survey (n = 23,752). Six GBD-defined groups were included: RMDs, chronic obstructive pulmonary disease or asthma, cancer, depression, diabetes or renal failure, and stroke or myocardial infarction. The empirical approach comprised the patterns "low disease probability", "cardiometabolic conditions", "respiratory conditions" and "RMDs and depression". As recommended by the outcome measures in rheumatology (OMERACT) initiative, health outcomes included life impact, pathophysiological manifestations, and resource use indicators. Population attributable fractions (PAF) were computed for each outcome and bootstrap confidence intervals (95% CI) were estimated. Among GBDdefined groups, RMDs had the highest impact across all the adverse health outcomes, from frequent healthcare utilization (PAF 7.8%, 95% CI 6.2-9.3) to negative self-rated health (PAF 18.1%,). In the empirical approach, patterns "cardiometabolic conditions" and "RMDs and depression" had similar PAF estimates across all adverse health outcomes, but "RMDs and depression" showed significantly higher impact on chronic pain (PAF 8.9%, 95% CI 7.6-10.3) than the remaining multimorbidity patterns. RMDs revealed the greatest population impact across all adverse health outcomes tested, using both approaches. Empirical patterns are particularly interesting to evaluate the impact of RMDs in the context of their co-occurrence with other NCDs.

show abstract

“…Przykładowo, ponad 20% orzeczeń niezdolności do pracy w Wielkiej Brytanii jest związanych z chorobami reumatycznymi, a łączne roczne koszty leczenia chorego na RZS wynoszą średnio 7000 £. W Grecji w 2005 r. choroby reumatyczne stanowiły ok. 39% wszystkich chorób przewlekłych i były przyczyną 47% przewlekłej niepełnosprawności oraz 26% krótkoterminowej niezdolności do pracy [21]. W Szwecji koszty chorób reumatycznych wynosiły 23% wszystkich kosztów i stanowiły największe obciążenie systemu opieki zdrowotnej [7].…”

Section: Aspekty Socjoekonomiczneunclassified

The effects of clinical, epidemiological and economic aspects of changes in classification criteria of selected rheumatic diseases

Owczarek¹,

Michalik²,

Kotyla³

et al. 2014

Reumatologia

View full text Add to dashboard Cite

S t r e s z c z e n i e W pracy przedstawiono epidemiologię i aspekty socjoekonomiczne trzech najczęstszych chorób reumatycznych: reumatoidalnego zapalenia stawów (RZS), tocznia rumieniowatego układowego (TRU) oraz twardziny układowej (TU). Częstość występowania chorób reumatycznych w populacji szacuje się na 4-5%. Współczynnik chorobowości dla RZS w Polsce wynosi 0,45% populacji dorosłej i jest zbliżony do współczynnika w Unii Europejskiej, który wynosi 0,49%. Szacuje się, że średnia częstość występowania tocznia rumieniowatego układowego wynosi 40-55/100 tys. osób. Roczna zapadalność na TU wynosi 19-35 przypadków na milion mieszkańców (w zależności od kraju, w którym przeprowadzono badania). W Polsce blisko 18% wszystkich hospitalizacji jest związanych ze schorzeniami reumatycznymi. Wprowadzenie nowych kryteriów klasyfikacyjnych dla RZS, umożliwiających klasyfikowanie wczesnych postaci choroby i szersze ich zastosowanie w praktyce klinicznej, wpłynie zapewne na zmianę oceny częstości występowania tej choroby w populacji. Adres do korespondencji:dr hab. n. o zdr. inż. Aleksander

show abstract

The burden of the rheumatic diseases in the general adult population of Greece: the ESORDIG study

Abstract: These findings suggest that rheumatic diseases constitute a major public health problem and should be considered in planning undergraduate and postgraduate medical education, research and health-care services.

Cited by 37 publications

References 15 publications

“Just Get on with It”: Qualitative Insights of Coming to Terms with a Deteriorating Body for Older Women with Osteoarthritis

“Just Get on with It”: Qualitative Insights of Coming to Terms with a Deteriorating Body for Older Women with Osteoarthritis

The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches

The effects of clinical, epidemiological and economic aspects of changes in classification criteria of selected rheumatic diseases

Contact Info

Product

Resources

About